摘要
The initiation of the National New Drug Innovation Key Technology Program marked a strategic shift of new drug discovery in China, which will greatly enhance the new drug discovery research activities. It presents a valuable opportunity for the growth and quality advancement of pharmaceutical science journals. As the only comprehensive English journal of the Chinese Pharmaceutical Association, In the new situation, Journal of Chinese Pharmaceutical Sciences （JCPS） plays a critical role in the communication of new discoveries in pharmaceutical researches to the scientific community. To fulfill the roles as an internationally recognized platform for the communication of the new drug discoveries supported by the National New Drug Innovation Programs, the JCPS editorial office will take advantage of its English language specialty, emphasize quality and digital access, and promote the advancement of the journal.
我国"重大新药创制"科技重大专项的实施,标志着我国创新药物研究战略的重大调整,也极大地促进了中国创新药物研究水平的提升,同时带来了药学期刊发展的春天。在新形势下,《中国药学》(英文版)作为中国药学会唯一的英文综合性期刊,发挥自身的语言优势,以打造我国创新药物研究成果展示平台和窗口为目标,突出特色,狠抓质量和数字化建设,积极与国际接轨,走上了良性发展之路。
